Start of the main text

Performance 1. Business Review

Steady Advances in R&D and Global Business

In R&D, Astellas has delivered numerous accomplishments in terms of steadily advancing late-stage clinical development projects, along with forming partnerships to acquire innovation. Moreover, business has expanded steadily in all the regions of Japan, the Americas, EMEA and Asia & Oceania, driven by XTANDI and overactive bladder (OAB) products.